A patient with newly diagnosed Cushing syndrome presents with proximal muscle weakness, hypertension, and poor glycemic control. Which nursing intervention should be prioritized to address the patient's cardiovascular risk?

A) Educate the patient on a low-sodium diet to help manage hypertension.

B) Initiate a daily exercise plan to improve muscle strength and glucose utilization.

C) Monitor blood glucose levels closely and adjust insulin as needed.

D) Collaborate with the healthcare provider to adjust antihypertensive medications.

A patient with Cushing syndrome presents with elevated blood glucose, hypertension, and hypokalemia. Which nursing intervention is most appropriate to address these clinical findings?

D) Initiate a referral to a dietitian for a carbohydrate-controlled diet to improve blood glucose levels.

A) Administer a potassium-sparing diuretic to manage hypokalemia.

B) Educate the patient on the importance of adhering to a low-sodium diet to help control hypertension.

C) Collaborate with the healthcare provider to adjust the patient's antihypertensive regimen to include an ACE inhibitor.

D) Initiate a referral to a dietitian for a carbohydrate-controlled diet to improve blood glucose levels.

A patient with resistant hypertension and hypokalemia is being considered for the addition of spironolactone to her treatment plan. She also has worsening glucose intolerance with elevated fasting and postprandial blood glucose levels. Which of the following nursing interventions is most appropriate to prioritize when monitoring this patient following the initiation of spironolactone and a GLP-1 receptor agonist?

C) Evaluate the patient for signs of pancreatitis, such as abdominal pain and elevated pancreatic enzymes.

A) Monitor for signs of hyperkalemia and educate the patient about reducing dietary potassium intake.

B) Assess for symptoms of hypoglycemia and ensure the patient has a supply of fast-acting carbohydrates.

C) Evaluate the patient for signs of pancreatitis, such as abdominal pain and elevated pancreatic enzymes.

D) Monitor for signs of orthostatic hypotension and advise the patient to change positions slowly.

A patient with hypertension and type 2 diabetes has been started on spironolactone and a GLP-1 receptor agonist. Despite improvements in potassium levels and blood glucose, the patient reports fatigue and lightheadedness, and is found to have mild orthostatic hypotension. What is the most appropriate nursing intervention to address the patient's orthostatic symptoms?

C) Educate the patient to rise slowly from sitting or lying positions.

A) Increase the patient's daily fluid intake.

B) Encourage the patient to consume more potassium-rich foods.

C) Educate the patient to rise slowly from sitting or lying positions.

D) Suggest reducing the dosage of the GLP-1 receptor agonist.

A patient with hypertension and type 2 diabetes has been started on spironolactone and a GLP-1 receptor agonist. She reports persistent fatigue and lightheadedness, with blood pressure readings of 140/90 mmHg supine and 125/85 mmHg standing. Which nursing intervention is most appropriate given her symptoms and current treatment regimen?

C) Educate her on rising slowly from sitting or lying positions

A) Increase her spironolactone dose to improve blood pressure control

B) Encourage her to consume more potassium-rich foods

C) Educate her on rising slowly from sitting or lying positions

D) Advise her to reduce her fluid intake to prevent fluid overload

A patient with a history of Cushing syndrome is experiencing increased bruising and delayed wound healing. She has been on long-term corticosteroid therapy. Laboratory tests reveal mildly elevated liver enzymes, slightly prolonged PT and aPTT, and a platelet count at the lower end of normal. Which nursing intervention is most appropriate to address her current condition?

B) Encourage a diet high in vitamin C and zinc to support wound healing.

A) Discontinue corticosteroid therapy immediately to prevent further complications.

B) Encourage a diet high in vitamin C and zinc to support wound healing.

C) Initiate a high-protein diet to improve liver function and coagulopathy.

D) Administer platelet transfusions to correct the low platelet count.

A patient with a history of Cushing syndrome and prolonged corticosteroid use presents with increased bruising and delayed wound healing. Laboratory findings indicate a mild coagulopathy and mildly elevated liver enzymes. What is the most appropriate nursing intervention to address the patient's condition?

B) Implement a gradual tapering of corticosteroids while monitoring coagulation status and liver function.

A) Increase the patient's corticosteroid dosage to improve immune response.

B) Implement a gradual tapering of corticosteroids while monitoring coagulation status and liver function.

C) Recommend a high-protein diet to promote liver regeneration.

D) Suggest complete cessation of corticosteroids to prevent further liver damage.

A patient with Cushing syndrome on corticosteroid therapy presents with jaundice and elevated liver enzymes. Which nursing intervention is most appropriate to prioritize in this scenario?

B) Educate the patient on the signs and symptoms of adrenal insufficiency.

A) Administer a high-protein diet to support liver regeneration.

B) Educate the patient on the signs and symptoms of adrenal insufficiency.

C) Monitor the patient's blood glucose levels closely.

D) Prepare the patient for possible liver biopsy to assess hepatic damage.

A patient with Cushing syndrome presents with jaundice, hepatomegaly, and elevated liver enzymes, suggesting corticosteroid-induced liver injury. Which intervention should the nurse prioritize to address the patient's liver condition while managing her Cushing syndrome?

C) Collaborate with the healthcare provider to adjust the corticosteroid regimen and incorporate hepatoprotective strategies.

A) Increase the corticosteroid dose to manage Cushing syndrome symptoms effectively.

B) Implement a high-protein diet to support liver regeneration.

C) Collaborate with the healthcare provider to adjust the corticosteroid regimen and incorporate hepatoprotective strategies.

D) Encourage the patient to increase physical activity to enhance liver function.

Cushing syndrome - Nursing Case Study

Pathophysiology

• Primary mechanism: Cushing syndrome is primarily caused by prolonged exposure to excessive glucocorticoids, often due to either endogenous overproduction (such as from an ACTH-secreting pituitary adenoma) or exogenous sources like corticosteroid medications. This leads to increased cortisol levels, which affect numerous body systems.

• Secondary mechanism: Elevated cortisol levels result in metabolic alterations, including increased gluconeogenesis and insulin resistance, contributing to hyperglycemia. Additionally, cortisol promotes protein breakdown and fat redistribution, leading to muscle wasting and characteristic central obesity.

• Key complication: Chronic exposure to high cortisol levels can lead to hypertension, osteoporosis, and immune suppression, significantly impacting patient morbidity and quality of life. Monitoring and managing these complications are critical for nursing care.

Patient Profile

Demographics:

45-year-old female, accountant

History:

• Key past medical history: Hypertension, Type 2 Diabetes

• Current medications: Metformin, Lisinopril, Hydrochlorothiazide

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Persistent fatigue and weight gain

• Key symptoms: Increased abdominal girth, facial rounding, easy bruising, muscle weakness, and mood swings

• Vital signs: Blood pressure 150/95 mmHg, heart rate 92 bpm, respiratory rate 18 breaths per minute, temperature 98.7°F, BMI 32 kg/m²

Section 1

During the initial assessment, the nursing team carefully evaluated the patient's symptoms and physical presentation. Notably, the patient exhibited pronounced striae on her abdomen, suggestive of skin changes associated with prolonged cortisol exposure. The presence of proximal muscle weakness was evident when the patient struggled to rise from a seated position without assistance, indicating potential muscle catabolism. A comprehensive skin examination revealed multiple bruises on her arms and legs, consistent with increased capillary fragility and delayed wound healing associated with Cushing syndrome. Given her history of hypertension and current blood pressure reading of 150/95 mmHg, there was a heightened concern for cardiovascular complications, necessitating close monitoring and potentially adjusting her antihypertensive regimen.

The nursing team prioritized obtaining further diagnostic results to assess the extent of metabolic derangements. Lab tests revealed elevated fasting blood glucose levels of 165 mg/dL, confirming poor glycemic control likely exacerbated by increased insulin resistance. Additionally, serum cortisol levels were markedly elevated at 30 µg/dL, reinforcing the suspicion of Cushing syndrome. A dexamethasone suppression test was ordered to differentiate between potential causes, such as an ACTH-secreting pituitary adenoma versus adrenal hyperplasia. The patient's potassium level was slightly decreased at 3.2 mEq/L, a finding that requires attention due to the risk of hypokalemia, which can further complicate her hypertension and glucose management.

As the case progresses, the focus will shift toward developing a comprehensive care plan addressing these interconnected complications. The interdisciplinary team must consider potential adjustments to her current medication regimen, particularly regarding her antihypertensive and diabetic medications. Furthermore, the patient will require education on lifestyle modifications to mitigate cardiovascular risks and support overall health. Close monitoring for signs of osteoporosis and immune suppression is paramount, with bone density scanning and immunization status review as potential next steps in her management.

Section 2

As the nursing team continued to monitor the patient, new complications emerged that required immediate attention and adjustment of the care plan. The patient's blood pressure remained persistently elevated despite adherence to her antihypertensive regimen, with new readings averaging 160/100 mmHg. This prompted the healthcare team to consult with her primary care physician to consider adding a mineralocorticoid receptor antagonist, such as spironolactone, to address possible hyperaldosteronism contributing to her resistant hypertension and hypokalemia. This adjustment aimed to stabilize her blood pressure while also counteracting the low potassium levels, which were now confirmed to be 3.0 mEq/L on repeat testing.

Concurrent with these developments, the patient began to exhibit signs of worsening glucose intolerance. Her fasting blood glucose climbed to 180 mg/dL, and postprandial levels exceeded 240 mg/dL, despite adherence to dietary recommendations and current diabetic medication. The team discussed the possibility of introducing a GLP-1 receptor agonist to enhance insulin secretion and sensitivity while promoting weight loss, which could further assist in managing her blood pressure and glucose levels. This decision necessitated careful consideration of potential interactions with her current medications and patient-specific factors, such as her risk for pancreatitis.

Moreover, the patient reported experiencing increased fatigue and occasional dizziness, raising concerns about potential orthostatic hypotension and electrolyte imbalances. A detailed review of her symptoms and medication regimen was initiated to rule out adverse effects or inadequate dosing adjustments. The interdisciplinary team emphasized the importance of a coordinated approach, ensuring all aspects of her complex condition were addressed. This included ongoing education about recognizing symptoms of electrolyte disturbances and the importance of medication adherence, alongside recommendations for regular follow-ups to track her response to the revised treatment plan and mitigate the risk of further complications.

Section 3

As the patient continued under observation, the interdisciplinary team focused on her response to the revised interventions. Following the addition of spironolactone to her regimen, there was a notable improvement in electrolyte balance, with her potassium levels rising to 3.8 mEq/L after one week. However, her blood pressure showed only a marginal improvement, with readings averaging 150/95 mmHg. This necessitated ongoing discussions about potential further adjustments, such as titrating her current antihypertensive medications.

Simultaneously, the introduction of a GLP-1 receptor agonist led to a promising reduction in her fasting blood glucose, which decreased to 150 mg/dL, and postprandial levels dropped to 210 mg/dL. Despite these improvements, her glucose levels remained above target, prompting the team to consider additional strategies, such as dietary modifications and increased physical activity, tailored to her endurance and preferences. The patient was counseled on the importance of maintaining a balanced diet that could synergize with her medication to optimize glucose control.

Despite these interventions, the patient reported persistent fatigue and occasional lightheadedness. A detailed reassessment revealed mild orthostatic hypotension, with blood pressure measurements of 140/90 mmHg while supine and dropping to 125/85 mmHg upon standing. The team hypothesized that the changes in her medication regimen, particularly the introduction of spironolactone, might contribute to these symptoms. Consideration was given to adjusting her dosing schedule and monitoring her fluid and salt intake closely. Additionally, the patient was educated on strategies to manage her orthostatic symptoms, such as rising slowly from sitting or lying positions and staying adequately hydrated. Regular follow-ups were scheduled to closely monitor her response and ensure that the treatment plan remained aligned with her evolving condition.

Section 4

As the patient continued with the adjusted treatment plan, the healthcare team observed a new complication during routine follow-up visits. The patient began experiencing episodes of increased bruising and delayed wound healing, which prompted further investigation. Considering her history of Cushing syndrome and prolonged exposure to corticosteroids, the team suspected possible impaired collagen synthesis and weakened immune response as contributing factors. To explore these concerns, a comprehensive set of diagnostic tests were ordered, including a complete blood count, coagulation profile, and tests to evaluate her liver and kidney function.

The results revealed a slightly prolonged prothrombin time (PT) and activated partial thromboplastin time (aPTT), suggesting a mild coagulopathy. Additionally, her platelet count was on the lower end of normal, at 150,000/mm³, which could further explain the increased bruising. Liver function tests showed mildly elevated transaminases, indicating possible hepatic involvement, a common finding in patients with Cushing syndrome due to fatty liver changes or steroid-induced liver injury. With these findings, the team deliberated on the need to adjust her corticosteroid therapy, considering a gradual tapering plan to minimize adrenal suppression while addressing her coagulopathy and liver function.

In response to these developments, the multidisciplinary team also considered potential nutritional deficiencies contributing to her symptoms. A dietary consultation was scheduled to assess her intake of vitamins and minerals essential for healing, such as vitamin C and zinc. The team reinforced the importance of a balanced diet to support her overall health and recovery. Furthermore, they planned to closely monitor her wound healing and adjust her treatment plan as necessary, while educating her on protective measures to minimize injury risks. Regular monitoring of her coagulation profile and liver function tests was also instituted to evaluate the effectiveness of the interventions and guide future clinical decisions.

Section 5

As the healthcare team continued to monitor the patient's condition, they observed a change in her status that warranted immediate attention. During a routine visit, the patient reported increased fatigue, mild abdominal discomfort, and a noticeable yellowing of her skin and eyes. Upon physical examination, her vital signs were stable, but there was evident jaundice and mild hepatomegaly upon palpation. These findings raised concerns about her liver function, prompting an expedited review of her recent liver function tests, which had previously shown mildly elevated transaminases.

Further diagnostic tests were promptly ordered to assess the extent of her hepatic dysfunction. Repeat liver function tests revealed a significant increase in bilirubin levels, now at 3.5 mg/dL, and further elevation of ALT and AST levels, suggesting a progression of liver impairment. The team also noted an increase in alkaline phosphatase, indicative of cholestasis. These results, coupled with her clinical presentation, suggested a possible corticosteroid-induced liver injury exacerbated by her underlying Cushing syndrome. Given the potential severity of her liver condition, the team deliberated on the urgent need to revise her corticosteroid regimen, balancing the risks of adrenal insufficiency with further hepatic deterioration.

The patient's response to these interventions was closely monitored, and her treatment plan was adjusted to incorporate hepatoprotective strategies while cautiously tapering her corticosteroid dosage. The team emphasized the importance of regular follow-up visits to re-evaluate her liver function and overall health status. They also educated the patient on recognizing signs of worsening liver function and the importance of adhering to her prescribed dietary modifications. This approach aimed to stabilize her condition, prevent further complications, and support her recovery in the context of her complex medical needs.